These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 17325841)
21. Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia. Gozzetti A; Musto P; Defina M; D'Auria F; Papini G; Statuto T; D'Arena G; Bocchia M Br J Haematol; 2012 May; 157(4):497-8. PubMed ID: 22296516 [No Abstract] [Full Text] [Related]
22. Thalidomide for the treatment of severe intestinal bleeding. Alberto SF; Felix J; de Deus J Endoscopy; 2008 Sep; 40(9):788; author reply 789. PubMed ID: 18773348 [No Abstract] [Full Text] [Related]
24. Combination therapy incorporating Bcl-2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14). Gonsalves WI; Buadi FK; Kumar SK Eur J Haematol; 2018 Feb; 100(2):215-217. PubMed ID: 29064593 [TBL] [Abstract][Full Text] [Related]
25. Thalidomide therapy in adult patients with myelodysplastic syndrome: a north central cancer treatment group phase II trial. Musto P Cancer; 2007 Mar; 109(6):1211-2; author reply 1212. PubMed ID: 17279582 [No Abstract] [Full Text] [Related]
26. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment. Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832 [TBL] [Abstract][Full Text] [Related]
27. Successful treatment of extensive infantile hemangiomatosis of the small bowel in a 3-month-old with thalidomide and somatostatin analog. Jarvi K; Roebuck DJ; Sebire NJ; Lindley K; Shah N; Salomon J; Curry JI J Pediatr Gastroenterol Nutr; 2008 May; 46(5):593-7. PubMed ID: 18493217 [No Abstract] [Full Text] [Related]
28. Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia. Johnston RE; Abdalla SH Leuk Lymphoma; 2002 Feb; 43(2):351-4. PubMed ID: 11999568 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of thalidomide in the treatment of multiple myeloma. Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865 [No Abstract] [Full Text] [Related]